Shanghai MicroPort MedBot (Group) Future Growth
Future criteria checks 2/6
Shanghai MicroPort MedBot (Group) is forecast to grow earnings and revenue by 77.9% and 77.1% per annum respectively. EPS is expected to grow by 82.2% per annum. Return on equity is forecast to be -60.7% in 3 years.
Key information
77.9%
Earnings growth rate
82.2%
EPS growth rate
| Medical Equipment earnings growth | 41.2% |
| Revenue growth rate | 77.1% |
| Future return on equity | -60.7% |
| Analyst coverage | Low |
| Last updated | 28 Nov 2024 |
Recent future growth updates
Recent updates
Why We're Not Concerned About Shanghai MicroPort MedBot (Group) Co., Ltd.'s (HKG:2252) Share Price
Aug 30
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Analysts Just Trimmed Their Revenue Forecasts By 58%
Apr 12Is Shanghai MicroPort MedBot (Group) (HKG:2252) Using Debt Sensibly?
Mar 29Is Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 24We're Not Very Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Rate
May 19Here's Why We're Not Too Worried About Shanghai MicroPort MedBot (Group)'s (HKG:2252) Cash Burn Situation
Feb 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,251 | 57 | 24 | 48 | 3 |
| 12/31/2025 | 686 | -268 | -191 | -169 | 3 |
| 12/31/2024 | 234 | -532 | -464 | -438 | 3 |
| 6/30/2024 | 156 | -750 | -417 | -377 | N/A |
| 3/31/2024 | 130 | -881 | -525 | -472 | N/A |
| 12/31/2023 | 105 | -1,012 | -634 | -568 | N/A |
| 9/30/2023 | 86 | -1,116 | -895 | -788 | N/A |
| 6/30/2023 | 68 | -1,220 | -1,154 | -1,008 | N/A |
| 3/31/2023 | 45 | -1,180 | -1,124 | -953 | N/A |
| 12/31/2022 | 22 | -1,140 | -1,093 | -898 | N/A |
| 9/30/2022 | 12 | -970 | -944 | -745 | N/A |
| 6/30/2022 | 3 | -800 | -794 | -591 | N/A |
| 3/31/2022 | 3 | -691 | -734 | -566 | N/A |
| 12/31/2021 | 2 | -583 | -674 | -540 | N/A |
| 9/30/2021 | 1 | -489 | -507 | -424 | N/A |
| 6/30/2021 | N/A | -396 | -340 | -308 | N/A |
| 3/31/2021 | N/A | -299 | -229 | -206 | N/A |
| 12/31/2020 | N/A | -203 | -118 | -103 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2252 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2252 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2252 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2252's revenue (77.1% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2252's revenue (77.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2252 is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 13:13 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicroPort MedBot (Group) Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Muk Tsz Yung | Citigroup Inc |
| Eva Zhao | Citigroup Inc |
| Dennis Ip | Daiwa Securities Co. Ltd. |